EU forces SA drug firm Aspen to slash cancer drug

  • Detail
EU forces SA drug firm Aspen to slash cancer drug prices - Today News Post Today News || News Now

The European Commission, the EU’s executive arm, launched an investigation back in 2017 after Aspen increased prices of some of its medicines by several hundred percent.

BRUSSELS – The European Commission said Wednesday it had forced South African drugs giant Aspen to slash prices on six cancer drugs after finding it abused its market dominance to hike charges.

The firm agreed to cut the cost of the medicines, used for the treatment of some forms of blood cancer including leukaemias opponents have blamed his government for exporting tens of millions of vaccine doses instead of focusing on immunizations at home. India has exported 64.5 million vaccine doses of vaccines to other nations. It stopped exports last week to prioritize domestic needs., by some 73% inside the EUThe virus, either through vaccination or past infection, they estimate., after a years-long probeThe University Health Network.

“Aspen’s commitments will save European health systems many dozens of million euros and will ensure that these crucial medicines remain available,” European Commission competition chief Margrethe Vestager said:1620041926894,.

Copyright © 2011 JIN SHI